2011 annual financial data
Sonoma Pharmaceuticals 2011 Net income growth
Direct answer
Net income growth was 3.45%.
Operating income was -7,505,000 USD and net income was -7,948,000 USD.
Operating cash flow was -4,429,000 USD.
Get free Sonoma Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 9,754,000 USD
- Operating income
- -7,505,000 USD
- Net income
- -7,948,000 USD
- Operating cash flow
- -4,429,000 USD